Ensysce Biosciences reported total assets of $7.45M and total liabilities of $4.24M for the quarter ended Dec 2025, up 33.1% year over year. This balance sheet covers 33 quarters of results from Dec 2017 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 0.02M | 8.01M | 6.85M | 12.26M | 8.44M | 3.73M | 4.50M | 3.15M | 1.42M | 3.83M | 1.46M | 1.12M | 3.40M | 1.04M | 4.15M | 3.50M | 3.05M | 2.21M | 1.67M | 4.31M | |||||||||||||
| Cash & Current Investments | 0.02M | 8.01M | 6.85M | 12.26M | 8.44M | 3.73M | 4.50M | 3.15M | 1.42M | 3.83M | 1.46M | 1.12M | 3.40M | 1.04M | 4.15M | 3.50M | 3.05M | 2.21M | 1.67M | 4.31M | |||||||||||||
| Receivables - OtherOther Receivables | 0.08M | 0.09M | 0.44M | 0.81M | 0.28M | 0.14M | 0.28M | 0.29M | 0.11M | 0.11M | 0.10M | 0.10M | 0.22M | 1.78M | 0.12M | 0.02M | 1.20M | 0.00M | 0.42M | ||||||||||||||
| Prepaid Assets | 0.19M | 0.26M | 1.96M | 2.93M | 2.39M | 3.17M | 2.98M | 1.85M | 1.65M | 1.91M | 1.18M | 1.07M | 1.20M | 1.19M | 3.15M | 1.34M | 1.33M | 1.87M | 1.25M | 2.51M | |||||||||||||
| Current Assets | 0.23M | 8.36M | 8.92M | 15.66M | 11.66M | 7.19M | 7.66M | 5.30M | 3.37M | 5.86M | 2.76M | 2.29M | 4.70M | 2.46M | 9.09M | 5.34M | 4.40M | 5.28M | 2.93M | 7.25M | |||||||||||||
| Non-Current Assets | |||||||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 50.00 | 0.12M | 0.12M | ||||||||||||||||||||||||||||||
| Long-Term Investments | 12.69M | ||||||||||||||||||||||||||||||||
| Long-Term Deferred Tax | |||||||||||||||||||||||||||||||||
| Other Non-Current Assets | 0.84M | 0.80M | 0.75M | 0.71M | 0.75M | 0.63M | 0.59M | 0.54M | 0.50M | 0.46M | 0.42M | 0.38M | 0.34M | 0.29M | 0.25M | 0.21M | 0.29M | 0.13M | 0.17M | ||||||||||||||
| Non-Current Assets | 12.75M | 0.84M | 0.80M | 0.75M | 0.71M | 0.75M | 0.63M | 0.59M | 0.54M | 0.50M | 0.46M | 0.42M | 0.38M | 0.34M | 0.29M | 0.25M | 0.21M | 0.29M | 0.25M | 0.21M | |||||||||||||
| Assets | 12.98M | 9.20M | 9.72M | 16.42M | 12.37M | 7.95M | 8.29M | 5.89M | 3.91M | 6.36M | 3.22M | 2.71M | 5.07M | 2.80M | 9.38M | 5.60M | 4.61M | 5.57M | 3.18M | 7.45M | |||||||||||||
| Liabilities | |||||||||||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||||||||||
| Accounts Payables | 0.32M | 3.14M | 0.47M | 0.30M | 0.96M | 3.05M | 1.29M | 2.94M | 1.60M | 1.27M | 0.92M | 1.94M | 0.98M | 0.48M | 1.97M | 1.36M | 0.62M | 1.04M | 0.46M | 3.27M | |||||||||||||
| Notes Payables | 2.80M | 12.75M | 6.07M | 2.52M | 7.55M | 4.27M | 0.45M | 0.35M | 0.85M | 0.25M | 0.45M | 0.39M | 0.30M | 0.26M | 0.42M | 0.39M | 0.31M | ||||||||||||||||
| Payables | 0.32M | 3.14M | 3.27M | 13.05M | 7.03M | 5.57M | 8.84M | 7.21M | 1.60M | 1.72M | 1.27M | 2.79M | 1.23M | 0.94M | 2.35M | 1.66M | 0.87M | 1.47M | 0.85M | 3.57M | |||||||||||||
| Accumulated Expenses | 0.41M | ||||||||||||||||||||||||||||||||
| Other Accumulated Expenses | 0.41M | 3.73M | 3.41M | 1.75M | 2.67M | 2.24M | 2.23M | 2.36M | 0.79M | 0.76M | 0.54M | 0.41M | 0.37M | 0.45M | 0.55M | 0.89M | 1.05M | 1.45M | 0.99M | ||||||||||||||
| Current Taxes | |||||||||||||||||||||||||||||||||
| Total Current Liabilities | 0.32M | 4.03M | 7.03M | 16.48M | 8.80M | 8.25M | 11.91M | 9.46M | 3.98M | 2.52M | 2.03M | 3.33M | 1.64M | 1.31M | 2.80M | 2.21M | 1.76M | 2.51M | 2.30M | 4.57M | |||||||||||||
| Non-Current Liabilities | |||||||||||||||||||||||||||||||||
| Non-Current Debt | 0.47M | 7.98M | 25.28M | 10.12M | 3.15M | 11.74M | 4.55M | 0.45M | 0.35M | 0.85M | 0.25M | 0.45M | 0.39M | 0.30M | 0.26M | 0.42M | 0.39M | 0.31M | |||||||||||||||
| Convertible Debt | 5.00M | 5.00M | |||||||||||||||||||||||||||||||
| Non-Current Deffered Revenue | 2.00M | ||||||||||||||||||||||||||||||||
| Preferred Stock Liabilities | |||||||||||||||||||||||||||||||||
| Minority Interest | -0.24M | -0.28M | -0.28M | -0.28M | -0.31M | -0.33M | -0.32M | -0.32M | -0.33M | -0.33M | -0.33M | -0.33M | -0.33M | -0.33M | -0.33M | -0.33M | -0.33M | -0.33M | -0.33M | ||||||||||||||
| Non-Current Deferred Tax LiabilityNon-Current Deferred Tax | |||||||||||||||||||||||||||||||||
| Other Non-Current Liabilities | 8.31M | 0.96M | 3.65M | 0.87M | 0.36M | 1.41M | 0.31M | 0.03M | 0.01M | 0.13M | 0.00M | 35.00 | |||||||||||||||||||||
| Total Non-Current Liabilities | 11.98M | 3.07M | 8.09M | 2.46M | 8.39M | 2.80M | 0.45M | 0.09M | 0.05M | 0.03M | 0.03M | 0.02M | 0.01M | 0.00M | 0.01M | 0.13M | 0.00M | 35.00 | |||||||||||||||
| Total Liabilities | 20.28M | 4.03M | 10.10M | 24.58M | 11.26M | 8.75M | 14.71M | 9.91M | 4.07M | 2.56M | 2.06M | 3.36M | 1.65M | 1.32M | 2.80M | 2.22M | 1.89M | 2.51M | 1.98M | 4.24M | |||||||||||||
| Shareholder's Equity | |||||||||||||||||||||||||||||||||
| Total Debt | 0.47M | 10.78M | 38.03M | 16.19M | 5.67M | 19.29M | 8.81M | 0.45M | 0.35M | 0.85M | 0.25M | 0.45M | 0.39M | 0.30M | 0.26M | 0.42M | 0.39M | 0.31M | |||||||||||||||
| Common Equity | -7.30M | 5.17M | -0.39M | -8.16M | 1.11M | -0.80M | -6.42M | -4.03M | -0.15M | 3.79M | 1.16M | -0.65M | 3.42M | 1.48M | 6.58M | 3.38M | 2.72M | 3.06M | 1.20M | 3.21M | |||||||||||||
| Liabilities and Shareholders Equity | 12.98M | 9.20M | 9.72M | 16.42M | 12.37M | 7.95M | 8.29M | 5.89M | 3.91M | 6.36M | 3.22M | 2.71M | 5.07M | 2.80M | 9.38M | 5.60M | 4.61M | 5.57M | 3.18M | 7.45M | |||||||||||||
| Retained Earnings | -2.92M | -57.84M | -75.01M | -85.85M | -87.51M | -95.51M | -105.41M | -110.93M | -113.13M | -115.40M | -118.05M | -121.56M | -124.67M | -126.64M | -125.98M | -129.54M | -131.49M | -133.22M | -136.95M | -139.72M |
Pull Ensysce Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=ENSC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "ENSC", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=ENSC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();